Dynavax Technologies Corp (DVAX)

Add to Watchlists
Create an Alert
6.41 -0.02  -0.31% NASDAQ Apr 18, 20:00 Delayed 2m USD
View Full Chart
DVAX Price Chart
View All Events

DVAX Events

Date Type Description
05/08/2019 16:30 EDT Misc Dynavax Technologies Corp First Quarter Earnings Conference Call in 2019
05/08/2019 Earnings Dynavax Technologies Corp First Quarter Earnings in 2019 Release
02/26/2019 16:30 EST Misc Dynavax Technologies Corp Fourth Quarter Earnings Conference Call in 2018
02/26/2019 Earnings Dynavax Technologies Corp Fourth Quarter Earnings in 2018 Release
11/05/2018 16:30 EST Misc Dynavax Technologies Corp Third Quarter Earnings Results in 2018
11/05/2018 Earnings Dynavax Technologies Corp Third Quarter Earnings Results in 2018 Release
08/06/2018 16:30 EDT Misc Dynavax Technologies Corp Second Quarter Earnings Results in 2018
08/06/2018 Earnings Dynavax Technologies Corp Second Quarter Earnings Results in 2018 Release
05/31/2018 Misc Dynavax Technologies Corp Annual General Meeting in 2017
05/08/2018 Earnings Dynavax Technologies Corp First Quarter Earnings Results in 2018 Release
View All Performance Charts

DVAX Total Returns Comparison

Advertisement

DVAX One Page Reports

Edit

Profile

  • URL: http://www.dynavax.com
  • Investor Relations URL: http://investors.dynavax.com/index.cfm
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: May. 08, 2019
  • Last Earnings Release: Feb. 26, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. It's current product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Dynavax operates in the business segment the discovery and development of biopharmaceutical products. Its Toll-like Receptor Immune Modulation Platform technology play a vital role in innate immunity and subsequent adaptive immunity. Signaling through these receptors is triggered by the binding of a variety of pathogen-associated molecules and is essential to the generation of innate immunity.

DVAX Comparables

Edit

DVAX Excel Add-In Codes

  • Name: =YCI("DVAX","name")
  • Description: =YCI("DVAX","description")
  • Sector: =YCI("DVAX","sector")
  • Industry: =YCI("DVAX","industry")
  • Est. Current Fiscal Year End: =YCI("DVAX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.